1. Transfusion studies in von Willebrand's disease: effect on bleeding time and factor VIII;Cornu, P.; Larrieu, M.J.; Caen, J.P.; Bernard, J.;Brit. J. Haemat,1963
2. The potent antihemophilic globulin concentrate derived from a cold insoluble fraction of human plasma;Hershgold, E.J.; Pool, J.G.; Pappenhagen, A.R.;J. Lab. clin. Med,1966
3. Purification of antihemophilic factor (AHF) for clinical and experimental use;Johnson, A.J.; Newman, J.; Howell, M.B.; Puszkin, S.;Thrombos. Diathes. haemorrh. (Stuttg.),1967
4. Congenital bleeding disorders with bleeding, time and normal platelet count;Larrieu, M.J.; Caen, J.P.; Meyer, D.O.; Vainer, H.; Sultan, Y.; Bernard, J.;II. von Willebrand's disease. Amer. J. Med,1968
5. Protein measurement with the Folin phenol reagent;J. biol. Chem,1951